Early prediction and mechanism of the Ribavirin/IFN-α dual therapy effect on chronic hepatitis C virus (HCV) infection.

被引：0
|
作者：
Neumann, AU
Dahari, H
Conrad, A
Pianko, S
McHutchinson, JG
机构：
[1] Bar Ilan Univ, Ramat Gan, Israel
[2] Natl Inst Genet, Los Angeles, CA USA
[3] Scripps Clin, La Jolla, CA USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
595
引用
收藏
页码：309A / 309A
页数：1
相关论文
共 50 条
  • [21] Inhibition of interferon-γ production by ribavirin in patients with chronic hepatitis C virus infection.
    Bürger, E
    Mihm, S
    Ramadori, G
    HEPATOLOGY, 1998, 28 (04) : 697A - 697A
  • [22] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13): : 975 - 982
  • [23] Rapid viral clearance with IFN-α 2b induction therapy and ribavirin for chronic HCV infection
    Bjoro, K
    Bell, H
    Hellum, KB
    Myrvang, B
    Skaug, K
    JOURNAL OF HEPATOLOGY, 2000, 32 : 38 - 38
  • [24] Effect of liver-directed IFN-γ gene delivery in chronic hepatitis C virus infection
    Shin, EC
    Protzer, U
    Untergasser, A
    Hasselschwert, D
    Rice, CM
    Feinstone, SM
    Rehermann, B
    FASEB JOURNAL, 2004, 18 (04): : A91 - A92
  • [25] Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-α/Ribavirin
    Amati, L
    Caradonna, L
    Magrone, T
    Mastronardi, ML
    Cuppone, R
    Cozzolongo, R
    Manghisi, OG
    Caccavo, D
    Amoroso, A
    Jirillo, E
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (11) : 981 - 993
  • [26] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [27] Effect of 12 month αIFN and Ribavirin combination therapy in chronic hepatitis C unresponsive to αIFN
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Idéo, GM
    Mondazzi, L
    Brasca, P
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [28] Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection
    Hoofnagle, Jay H.
    Wahed, Abdus S.
    Brown, Robert S., Jr.
    Howell, Charles D.
    Belle, Steven H.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (08): : 1112 - 1120
  • [29] Hepatitis C virus (HCV) dynamics during induction therapy with interferon (IFN) alpha and/or ribavirin.
    Pawlotsky, JM
    Neumann, AU
    Dahari, H
    Conrad, A
    Hezode, C
    Lonjon, I
    Germanidis, G
    Schmid, P
    Dhumeaux, D
    HEPATOLOGY, 2000, 32 (04) : 223A - 223A
  • [30] Risk factors for the progression of chronic hepatitis C (HCV) infection.
    Rai, R
    Gruskin, L
    Nelson, K
    Vlahov, D
    Astemborski, J
    Thomas, D
    GASTROENTEROLOGY, 1997, 112 (04) : A1363 - A1363
12345